Patient support groups help people overcome fear and confusion when switching to generic medications by sharing real experiences, building trust, and improving adherence-leading to better health and big cost savings.
Prescriber override lets doctors block generic drug substitutions when medically necessary. But confusing state rules, poor documentation, and unnecessary overrides are putting patients at risk and driving up costs.
Drug companies are using legal loopholes to block cheaper generics by withdrawing original drugs before generics can enter. This tactic, called product hopping, costs billions and violates antitrust law. Regulators are now taking action.
